Prospecto:information for the user
Dutasteride/Tamsulosin Combix Pharma0.5 mg/0.4 mg hard EFG capsules
dutasteride/hydrochloride of tamsulosin
Read this prospect carefully before starting to use this medication,because it contains important information for you.
-This medication has been prescribedonlyto you, and you should not give it to other people even if they havethe same symptomsas you, as it may harm them.
1.What is Dutasteride/Tamsulosin Combix Pharmaand for what it is used
2.What you need to knowbeforestarting totake Dutasteride/Tamsulosin Combix Pharma
3.How to take Dutasteride/Tamsulosin Combix Pharma
4.Possible adverse effects
5Storage of Dutasteride/Tamsulosin Combix Pharma
6.Contents of the package and additional information
Dutasterida/Tamsulosina Combix Pharmais used in men to treat an enlarged prostate (benign prostatic hyperplasia) - a non-cancerous growth of the prostate caused by producing an excess of a hormone called dihydrotestosterone.
Dutasterida/Tamsulosina Combix Pharmais a combination of two different medications called dutasteride and tamsulosin. Dutasteride belongs to a group of medications called 5-alpha reductase inhibitors and tamsulosin belongs to a group of medications called alpha blockers.
As the prostate grows in size, it may produce urinary problems such as difficulty in urinating and a need to urinate more frequently. It may also cause the urine stream to be smaller and less forceful. If benign prostatic hyperplasia is not treated, there is a risk of the urine flow being completely blocked (acute urinary retention). This requires immediate medical treatment. In some cases, surgery may be necessary to reduce the size of the prostate or to remove it.
Dutasteride reduces the production of dihydrotestosterone, which helps to reduce the size of the prostate and alleviate symptoms. This reduces the risk of acute urinary retention and the need for surgery. Tamsulosin acts by relaxing the muscles of the prostate, making urination easier and rapidly improving symptoms.
Do not takeDutasteride/Tamsulosin Combix Pharma:
Warnings and precautions
Consult your doctor before starting to take this medication.
Use ofDutasteride/Tamsulosin Combix Pharmawith other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Do not take dutasteride/tamsulosin with these medications:
Do not take dutasteride/tamsulosin with these medications:
Certain medications may interact with dutasteride/tamsulosin, which may increase the risk of adverse effects. Some of these medications are:
Administration ofDutasteride/Tamsulosin Combix Pharmawith food and beverages
You should take this medication 30 minutes after the same meal every day.
Pregnancy, breastfeeding, and fertility
Women should not take this medication
Women who are pregnant (or may be pregnant) should avoid contact with broken capsules. Dutasteride is absorbed through the skin and may affect the normal development of the male fetus. This risk is especially important in the first 16 weeks of pregnancy.
Use a condom during sexual intercourse.Dutasteride has been found in the semen of men taking this medication. If your partner is pregnant or thinks she may be pregnant, you should avoid exposing her to your semen.
This medication has been shown to decrease sperm count, motility, and semen volume. This may reduce your fertility.
Driving and operating machinery
Some people may experience dizziness during treatment with this medication, which may affect their ability to drive or operate machinery safely.
Dutasteride/Tamsulosin Combix Pharmacontains lecithin from soy, propylene glycol, and sodium
This medication contains lecithin from soy, so it may contain soy oil. Do not use this
medication if you are allergic to peanuts or soy.
This medication contains less than 23 mg of sodium (1 mmol) per capsule; it is essentially "sodium-free".
This medication contains 299 mg of propylene glycol per capsule.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If you do not take dutasterida/tamsulosina regularly, the control of your PSA levels may be affected. In case of doubt, consult your doctor or pharmacist again.
What dose should you take
The recommended dose is one capsule once a day, 30 minutes after the same meal every day.
How to take it
The capsules should be swallowed whole, with water. Do not chew or break the capsules. Contact with the contents of the capsules may irritate your mouth or throat.
If you take more Dutasterida/Tamsulosina Combix Pharma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Dutasterida/Tamsulosina Combix Pharma
Do not take a double dose to compensate for the missed doses. Take the next dose at the usual time.
If you interrupt the treatment with Dutasterida/Tamsulosina Combix Pharma
Do not interrupt treatment with this medication without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Allergic reaction
The symptoms of an allergic reaction may include:
Dizziness, lightheadedness, and fainting
This medicine may cause dizziness, lightheadedness, and, in rare cases, fainting. You should be careful when getting up quickly after sitting or lying down, especially if you have to get up during the night, until you know how this medicine affects you. If you feel dizzy or experience lightheadedness during treatment, sit or lie down until these symptoms have disappeared.
Severe skin reactions
The signs of severe skin reactions may include:
Common side effects
These may affect up to 1 in 10 men taking this medicine:
*In a small number of people, some of these adverse events may continue after stopping this medicine.
Uncommon side effects
These may affect up to 1 in 100 men:
Rare side effects
These may affect up to 1 in 1,000 men:
Very rare side effects
These may affect up to 1 in 10,000 men:
Other side effects
Other side effects have occurred in a reduced number of men but the exact frequency is unknown (the frequency cannot be estimated from the available data):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the bottle after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofDutasteride/Tamsulosin Combix Pharma
The active principles are dutasteride and hydrochloride of tamsulosin.Each capsule contains0.5 mg of dutasteride and 0.4 mg of hydrochloride of tamsulosin (equivalent to 0.367 mg of tamsulosin). The other components are:
Capsule hard shell:
Black iron oxide (E172)
Red iron oxide (E172)
Titanium dioxide (E171)
Yellow iron oxide (E172)
Gelatin
Content of the soft capsule of dutasteride:
Propylene glycol monocaprylate type II
Butylhydroxytoluene (E321)
Capsule soft shell:
Gelatin
Glycerol
Titanium dioxide (E171)
Medium-chain triglycerides
Soy lecithin (may contain soy oil) (see section 2)
Tamsulosin pellets:
Copolymer of methylacrylic acid and ethyl acrylate (1:1) dispersion 30 percent (also contains polysorbate 80 and sodium lauryl sulfate)
Microcrystalline cellulose
Dibutyl sebacate
Polysorbate 80
Colloidal hydrated silica
Calcium stearate
Tintas negras:
Shellac (E904)
Black iron oxide (E172)
Propylene glycol (E1520)
Concentrated ammonia solution (E527)
Potassium hydroxide (E525)
Section 2 “Dutasteride/Tamsulosin Combix Pharmacontains soy lecithin and propylene glycol”
Appearance of the product and contents of the package
This medicine is a hard gelatin capsule, oblong, approximately 24.2 mm x 7.7 mm, with a brown body and beige cap, engraved with C001 in black ink.
Each hard capsule contains modified-release pellets of hydrochloride of tamsulosin and a soft gelatin capsule with dutasteride.
It is available in packages of 7, 30, and 90 capsules.
Only some package sizes may be marketed.
Marketing authorization holder and responsible for manufacturing
Marketing authorization holder
Combix Laboratories, S.L.U.
C/ Badajoz 2, Building 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Leon Pharma Laboratories, SA
C/ La Vallina, s/n, Industrial Park Navatejera
Villaquilambre-24193 (León)
Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
DenmarkDutatex
GreeceZYTODUR 0.5 mg/0.4 mg,σκληρ?καψ?κια
PolandDutasteride + Tamsulosin hydrochloride León
Farma, 0.5 mg + 0.4 mg, hard capsules
PortugalDutasterida + Tansulosina Bluepharma
CroatiaAtekago 0,5 mg/0,4 mg hard capsules
Last review date of thisleaflet:August 2019
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.